<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01987258</url>
  </required_header>
  <id_info>
    <org_study_id>H-3-2012-141</org_study_id>
    <nct_id>NCT01987258</nct_id>
  </id_info>
  <brief_title>The Acute Effect of Interval-walking</brief_title>
  <acronym>acute IWS</acronym>
  <official_title>The Acute Effect of Interval-walking</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Four months of interval walking training (IWT) is superior to energy-expenditure matched
      continuous walking training (CWT) with regards to weight loss and improvements in glycemic
      control. The reason for this is unclear. One potential explanation for the differential
      outcome in weight loss is excess post-exercise oxygen consumption (EPOC), which is defined as
      the elevated oxygen consumption measured during the hours following an exercise bout. A large
      EPOC means greater energy expenditure which, if energy intake does not change, leads to a
      greater weight loss. This weight loss may subsequently improve glycemic control

        -  Aim 1: To assess the effect of an acute bout of IWT vs. an acute bout of CWT on glycemic
           control in type 2 diabetics and to assess mechanisms responsible for differences (if
           any). It is hypothesised that IWT will be more advantageous for improving glycemic
           control.

        -  Aim 2: To examine the effect of an acute bout of IWT vs. an acute bout of CWT on EPOC.
           It is hypothesised that IWT will produce an EPOC of larger magnitude than CWT.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>Will be assessed immediately after the intervention using a mixed meal tolerance test (duration: 5 hours) followed by continuous glucose monitoring (duration: 48 hours).</time_frame>
    <description>Glycemic control will be assessed after a one hour specific exercise intervention (control/continuous walking/interval walking) in a controlled setting (a mixed meal tolerance test). Moreover, glycemic control will be assessed during the following 2 days in a free-living environment, using continuous glucose monitoring systems.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Excess post-exercise oxygen consumption (EPOC)</measure>
    <time_frame>Will be assessed immediately after the intervention using a ventilated hood (duration: 5 hours).</time_frame>
    <description>EPOC will be assessed during the hours following the before-mentioned specific exercise bouts using the indirect calorimetry ventilated hood technique.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No exercise (control experiment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interval Walking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A one hour interval walking exercise bout</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous walking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A one hour continuous walking exercise bout</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interval Walking</intervention_name>
    <arm_group_label>Interval Walking</arm_group_label>
    <other_name>Interval exercise</other_name>
    <other_name>Interval training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Continuous walking</intervention_name>
    <arm_group_label>Continuous walking</arm_group_label>
    <other_name>Continuous exercise</other_name>
    <other_name>Continuous training</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes mellitus, type 2

        Exclusion Criteria:

          -  Smoking

          -  Pregnancy

          -  insulin dependence

          -  Contraindication to physical activity (as judged by medical history and screening)

          -  Evidence of thyroid, liver, lung, kidney or heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristian Karstoft, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641, DK-2100 Copenhagen, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2013</study_first_submitted>
  <study_first_submitted_qc>November 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2013</study_first_posted>
  <last_update_submitted>February 26, 2014</last_update_submitted>
  <last_update_submitted_qc>February 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Inge Holm</investigator_full_name>
    <investigator_title>Administrator</investigator_title>
  </responsible_party>
  <keyword>Glycemic control</keyword>
  <keyword>excess post-exercise oxygen consumption</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

